Lila Collins, PhD A few weeks ago we held a Facebook Live "Ask the Stem Cell Team About Parkinson's Disease" event. As you can imagine we got lots of questions but, because of time constraints, only had time to answer a few. Thanks to my fabulous CIRM colleagues, Dr. Lila Collins and Dr. Kent Fitzgerald, … Continue reading Parkinson’s Disease and Stem Cells
Scripps Research Institute
CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
Coronavirus particles, illustration. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved new clinical trials for COVID-19 and sickle cell disease (SCD) and two earlier stage projects to develop therapies for COVID-19. Dr. Michael Mathay, of the University of California at San Francisco, was awarded $750,000 for a clinical trial testing … Continue reading CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
Facebook Live: Ask the Stem Cell Team
On December 12th we hosted our latest 'Facebook Live: Ask the Stem Cell Team' event. This time around we really did mean team. We had a host of our Science Officers answering questions from friends and supporters of CIRM. We got a lot of questions and didn't have enough time to address them all. So … Continue reading Facebook Live: Ask the Stem Cell Team
Researcher claims to have made first gene-edited baby. But did it really happen?
Remember the Raelians? Probably not. But way back in 2002 the group, some described them as a cult, claimed it had created the world’s first cloned baby. The news made headlines all around the world raising fears we were stepping into uncharted scientific territory. Several weeks later the scientist brought in by the Raelians to … Continue reading Researcher claims to have made first gene-edited baby. But did it really happen?
Japanese scientists implant first Parkinson’s patient with replacement neurons derived from stem cells
Currently, more than 10 million people worldwide live with Parkinson’s disease (PD). By 2020, in the US alone, people living with Parkinson’s are expected to outnumber the cases of multiple sclerosis, muscular dystrophy and Lou Gehrig’s disease combined. There is no cure for Parkinson’s and treatment options consist of medications that patients ultimately develop tolerance … Continue reading Japanese scientists implant first Parkinson’s patient with replacement neurons derived from stem cells
Stem Cell Agency Invests in New Immunotherapy Approach to HIV, Plus Promising Projects Targeting Blindness and Leukemia
While we have made great progress in developing therapies that control the AIDS virus, HIV/AIDS remains a chronic condition and HIV medicines themselves can give rise to a new set of medical issues. That’s why the Board of the California Institute for Regenerative Medicine (CIRM) has awarded $3.8 million to a team from City of Hope … Continue reading Stem Cell Agency Invests in New Immunotherapy Approach to HIV, Plus Promising Projects Targeting Blindness and Leukemia
Using biological “codes” to generate neurons in a dish
Investigators at the Scripps Research Institute are making brain waves in the field of neuroscience. Until now, neuroscience research has largely relied on a variety of animal models to understand the complexities of various brain or neuronal diseases. While beneficial for many reasons, animal models do not always allow scientists to understand the precise mechanism … Continue reading Using biological “codes” to generate neurons in a dish
Celebrating Exciting CIRM-Funded Discovery Research on World Parkinson’s Day
April 11th is World Parkinson’s Disease Awareness Day. To mark the occasion, we’re featuring the work of CIRM-funded researchers who are pursuing new, promising ideas to treat patients with this debilitating neurodegenerative disease. Birgitt Schuele, Parkinson’s Institute CIRM Grant: Quest Award – Discovery Stage Research Research: Birgitt and her team at the Parkinson’s Institute in … Continue reading Celebrating Exciting CIRM-Funded Discovery Research on World Parkinson’s Day
Stem Cell RoundUp: CIRM Clinical Trial Updates & Mapping Human Brain
It was a very CIRMy news week on both the clinical trial and discovery research fronts. Here are some the highlights: Stanford cancer-fighting spinout to Genentech: 'Don't eat me' – San Francisco Business Times Ron Leuty, of the San Francisco Business Times, reported this week on not one, but two news releases from CIRM grantee … Continue reading Stem Cell RoundUp: CIRM Clinical Trial Updates & Mapping Human Brain
Scientists find switch that targets immunotherapies to solid tumors
Cancer immunotherapies harness the power of the patient’s own immune system to fight cancer. One type of immunotherapy, called adoptive T cell therapy, uses immune cells called CD8+ Killer T cells to target and destroy tumors. These T cells are made in the spleen and lymph nodes and they can migrate to different locations in … Continue reading Scientists find switch that targets immunotherapies to solid tumors
The Stem Cellar 